Augmented efficacy of uttroside B over sorafenib in a murine model of human hepatocellular carcinoma
M. Swetha, C. K. Keerthana, T. P. Rayginia, L. R. Nath, N. H. Haritha, K. Kalimuthu, S. Jannet, S. Pillai, K. B. Harikumar, S. Sundaram, N. P. Anto, D. H. Wu, R. S. Lankalapalli, R. Towner, N. Isakov, , R. J. Anto
This study compares the in vivo efficacy and safety of uttroside B and sorafenib in a murine model of hepatocellular carcinoma, finding Utt-B more potent and safer.
bioRxiv · Feb 1, 2022Cancer Biology